Predictors of mortality and end stage renal disease in Saudi patients with lupus nephritis.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1329, doi. 10.1177/0961203311415560
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2011 AND VI 20 AND IP 12
Results: 18
1
2
Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: A pilot study.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1293, doi. 10.1177/0961203311412098
- By:
- Publication type:
- Article
3
The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1285, doi. 10.1177/0961203311412097
- By:
- Publication type:
- Article
4
Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1275, doi. 10.1177/0961203311411598
- By:
- Publication type:
- Article
5
Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1267, doi. 10.1177/0961203311411597
- By:
- Publication type:
- Article
6
Systemic lupus erythematosus: Two sides of the same coin evaluated by cardiovascular magnetic resonance imaging.
- Published in:
- 2011
- By:
- Publication type:
- Letter
7
Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1250, doi. 10.1177/0961203311411350
- By:
- Publication type:
- Article
8
Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1260, doi. 10.1177/0961203311411347
- By:
- Publication type:
- Article
9
Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1231, doi. 10.1177/0961203311409963
- By:
- Publication type:
- Article
10
Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: An experimental mouse study.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1240, doi. 10.1177/0961203311409611
- By:
- Publication type:
- Article
11
Pregnancy in patients with undifferentiated connective tissue disease: a prospective case-control study.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1305, doi. 10.1177/0961203311409610
- By:
- Publication type:
- Article
12
Small muscle myositis in a patient with systemic lupus erythematosus successfully treated with rituximab.
- Published in:
- 2011
- By:
- Publication type:
- Letter
13
Antiphospholipid syndrome and relapsing polychondritis: an unusual association.
- Published in:
- 2011
- By:
- Publication type:
- Letter
14
Enhanced CCR5+/CCR3+ T helper cell ratio in patients with active cutaneous lupus erythematosus.
- Published in:
- Lupus, 2011, v. 20, n. 12, p. 1300, doi. 10.1177/0961203311409267
- By:
- Publication type:
- Article
15
Intestinal pseudo-obstruction syndrome in systemic lupus erythematosus.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
16
The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
17
Acute cerebellar ataxia in lupus.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
18
Antiphospholipid syndrome and rheumatic fever: a case spanning three decades of changing concepts and common immunological mechanisms.
- Published in:
- 2011
- By:
- Publication type:
- Case Study